Biomerica (BMRA) announced that the American Medical Association CPT editorial panel has issued a Current Procedural Terminology, CPT, code in the Proprietary Laboratory Analysis, PLA, code category for the Company’s inFoods IBS test. This newly granted PLA code assigns a unique identifier to the test, allowing for the submission of claims to Medicare and private insurers for the Company’s inFoods IBS test once the code becomes effective on October 1, 2025. The PLA code represents a next step on the pathway to expand patient access to the inFoods IBS test.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA:
- Biomerica announces appointment of Madel as Chief Commercial Officer
- Biomerica Appoints Eric B. Chin to Board
- Biomerica announces publication of data from inFoods IBS clinical study
- Biomerica announces real-world results of its inFoods IBS product
- Biomerica submits application for PLA code for inFoods IBS diagnostic test